VYNE Therapeutics Inc (VYNE)

[jugs]

We closed on Friday a week ago at $1.51.

And now with a couple of hours to go on another Friday, we are at $1.85. It's a gain of 34 cents for a percentile gain of 22.5%. While I'm ahead ever so slightly, I'm here for the long haul as I expect is the case for a growing number of investors here.

Even if we see much of the week's gain burn off as we head into the day's close, I'm confident we'll all feel amply rewarded for having remained longs in VYNE. Day traders will have their due and frankly their presence provides us with static enabling us longs to continue building positions destined to eventually become profitable.

So I hope this will reassure some. We are doing great! The company is looking better and better all the time with two FDA approvals on the board, the second of which will be launching commercially next month or thereabouts, a third is up for FDA review early in Q1 of 2021---and very exciting---as our country continues to reopen, things are looking better for us all the time.

There's plenty to appreciate. I hope nobody loses sight of our good fortune!